Navigation Links
Genetic and Proteomic Advances Pave the Way for Next-Generation Leukemia Therapies
Date:12/10/2011

(19 months vs. 34 months on average in DA arm vs. DAGO arm).

The treatment protocol had some toxicity, as the rate of fatal adverse events possibly attributable to treatment was 6.7 percent in the DA group and 8.7 percent in the DAGO group. Prolonged grade 3 or greater thrombocytopenia was observed in 19 DAGO patients, and three episodes of veno-occlusive disease or sinusoidal obstructive syndrome (liver vein blockages) were observed in the DAGO arm, two noted as fatal.  There were no differences between the arms in the incidence of severe sepsis or in the rate of intensive care unit admission during the course of therapy.

"Research has demonstrated that GO has very potent anti-cancer properties, and with this study we have identified a dosing regimen that gives patients the therapeutic benefit without some of the toxicities previously reported at higher doses," said lead author Sylvie Castaigne, MD, Professor in the Department of Hematology at Hopital de Versailles in Versailles, France. "Specialists treating AML have not been offered a new therapeutic option for several decades, and with this research we are encouraged that GO may be able to deliver better overall outcomes for these AML patients with limited alternatives."

Dr. Castaigne will present this study during the Plenary Scientific Session on Sunday, December 11, at 3:45 p.m. PST at the San Diego Convention Center in Hall AB.

Novel Chromosomal Rearrangements and Sequence Mutations in High-Risk Ph-Like Acute Lymphoblastic Leukemia [Abstract 67]

A recent study focusing on a unique subtype of high-risk B-cell acute lymphocytic leukemia (ALL) has used advanced genome sequencing to identify new targets for the treatment of this deadly blood cancer.

ALL is the most common pediatric malignancy, representing almost one-third of all childhood cancers. In particular, relapsed B-cell
'/>"/>

SOURCE American Society of Hematology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Signal Genetics Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product-MyPRS Plus™
2. VolitionRX Subsidiary Enters Into its First Revenue-Generating Agreement to Profile Blood-Based Epigenetic Signatures
3. Abbotts Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
4. Novel New Dog DNA Test Turns Breeders Into Genetic Matchmakers
5. Genetic Profile Identified for Alzheimers Patients Showing Heightened Response to Acceras Breakthrough Product Axona®
6. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
7. American College of Medical Genetics Applauds HHS Secretarys Decision to Expand Newborn Screening to Include Critical Congenital Heart Disease
8. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
9. The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977
10. Genetic Testing Can Help the US Cut Costs and Improve Health Care
11. Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015  Intec Pharma Ltd. (the ... company focused on developing drugs based on its proprietary ... its initial public offering in the United ... at a price to the public of $6.00 per ... the ordinary shares are being offered by the Company.  ...
(Date:8/4/2015)... NEW YORK , August 4, 2015 /PRNewswire/ ... new research report with market overview, trends, DRO ... analysis, recent developments, competitive scenario and top competitor ... of Abuse Testing Market Development and Demand ... http://photos.prnewswire.com/prnh/20150727/756778 ) , Explore full reports ...
(Date:8/4/2015)... Tenn., Aug. 4, 2015 Second Quarter ... 30.1% over second quarter of 2014 , Net earnings ... million; $51.2 million after adjustments , Diluted net earnings ... Adjusted EBITDA increased 15.2% to $99.4 million ... to a range of 24.0% to 26.0%; Adjusted EBITDA margin ...
Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 3Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 4Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 6Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 7Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 8Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 9Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 10Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 11Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 12Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 13Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 14Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 15Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 16Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 17Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 18Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 19Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 20Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 21Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 22Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 23Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 24Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 25Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 26Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 27Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 28Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 29Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 30
... Conference on Avian,Influenza at France's Pasteur Institute, PARIS, ... of,Novavax Inc.'s pandemic influenza vaccine provided protection,against a ... data presented here today at the Second International,Conference ... show that two 0.6 microgram doses of Novavax's,virus-like ...
... of Rare but Devastating,Condition , LONDON, June 1, ... of Leicester and have today (Friday June 1),announced ... rare but,devastating medical condition that can affect children ... clinicians and scientists from the two,universities have already ...
Cached Medicine Technology:Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5
(Date:8/5/2015)... ... August 05, 2015 , ... What language does a body ... unique “dictionary” of American idioms and other expressions that contain the name of a ... entertaining. This book contains about 2,000 such idioms, words, and expressions, for example, “back ...
(Date:8/5/2015)... ... August 05, 2015 , ... " Wildflower Seed & Tool Company ” ... look small, medium, and large businesses making an impact in their industry. Susan Bridges, ... with viewers how their gardening tools are specifically designed for women. , With overweight ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... funding, as well as awareness, education and support in order to reduce the ... Foundation proudly announces this year it has awarded the most funding in ...
(Date:8/4/2015)... (PRWEB) , ... August 05, 2015 , ... ... a Texas-based corporation, Crestwood Midstream, to store liquid propane gas (LPG) next to ... powerful healthcare workers union, unanimously passed a resolution that strongly opposes that permit. ...
(Date:8/4/2015)... , ... August 04, 2015 , ... NOVA Pride ... of whom or how they love or identify, to join them in paving “The ... Bull Run Special Events Center on Saturday, October 3, 2015, from 12-9pm. In order ...
Breaking Medicine News(10 mins):Health News:Harvard Medical Professor Dr. Per-Olof Hasselgren Pens Unique Book Using Body Part Idioms 2Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 2Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4
... medical condition, has been and remains under-identified. While it ... people who are at high risk for CKD are ... risk for potentially undiagnosed CKD, a team of public ... and the University of North Carolina (UNC) at Chapel ...
... carry a pronounced risk of suffering weak bones due ... Therefore, physicians need to be vigilant to spot bone ... the report the mix of sedentary behaviors and side ... in suppression of bone growth and mineralization. This makes ...
... turn with the involvement of social services in the case of ... above three times the average for his age. ,The ... does not undergo a sea change. He holds a record of ... ,Connor’s mother and grandmother are expected to attend a ...
... day for 10 years, a seemingly heart-healthy 53-year-old woman ... or family history of hypertension or hyperthyroidism. She did ... any abnormalities of the heart as best doctors and ... palpitations and dizziness nearly to the point of fainting. ...
... the most common treatments for prostate cancer - may increase ... age 65, according to a new study. ,The ... registry of men with prostate cancer. Although the findings need ... that oncologists should weigh the benefits of androgen deprivation therapy, ...
... with a drug used previously in the treatment of ... rats// to human subjects. ,The researchers ... administered daily to the rats which were bred to ... improvement in learning abilities. ,Down's syndrome is ...
Cached Medicine News:Health News:Simple Model to Predict Chronic Kidney Disease 2Health News:Simple Model to Predict Chronic Kidney Disease 3Health News:Bone Fragility, a Risk for Children With Cancer 2Health News:Grossly Overweight Boy Likely to Be Sent into Care 2Health News:Irregular Heartbeat Linked to Genetic Mutation 2Health News:Prostate Cancer Therapy may Increase Risk of Death in Older Patients 2Health News:Discredited Drug may Be Used to Aid Mental Development in Down’s Syndrome Patient 2
... sample processing consists of a clear glass ... a chemical-resistant polypropylene lid, and a set ... The manifold is designed for consistent processing ... simultaneously. Loading, washing, and elution steps can ...
For processing spin columns on QIAvac 24 or QIAvac 6S;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 96-well format...
Medicine Products: